Skip to main content
SpringerLink
Log in

Epidemiology and Management of Acute Decompensating Heart Failure in the Asia-Pacific Region

  • Chapter
Acute Heart Failure

  • 2463 Accesses

Abstract

Heart failure is a huge challenge worldwide, with acute decompensating heart failure syndromes being at the frontline of the problem. Health patterns are changing, with cardiovascular disease becoming the leading cause of mortality in developing countries, resulting globally in more heart failure, specifically in the Asia-Pacific region.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. CIA-World Fact Book. www.cia.gov./publications.

    Google Scholar 

  2. Leeder S, Raymond S, Greenburg H. A Race Against Time: The Challenge of Cardiovascular Disease in Developing Economies. New York: The Earth Institute at Columbia University, 2004.

    Google Scholar 

  3. Khor GL. Cardiovascular epidemiology in the Asia-Pacific region. Asia Pacific J Clin Nutr 2001;10(20):76–80.

    Article  CAS  Google Scholar 

  4. Wang L, Yao D, Wu T. Prevalence of Overweight and smoking patients with coronary heart disease in rural China. Aust J Rural Health 2004;12:17.

    Article  CAS  PubMed  Google Scholar 

  5. Jiang H, Dongfeng G, Xigui W, et al. Major causes of death among men and women in China. N Engl J Med 2005;353:1124–1132.

    Article  Google Scholar 

  6. Yusuf S, Hawkins S, Onupuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937–952.

    Article  PubMed  Google Scholar 

  7. Sekikawa A, Kuller LH, Ueshima H, et al. Coronary heart disease mortality trends in men in the post World War II birth cohorts aged 35–44 in Japan, South Korea and Taiwan compared to the United States. Int J Epidemiology 1999;28:1044–1049.

    Article  CAS  Google Scholar 

  8. Tatsanavivat P, Klungboonkrong V, Chirawatkul A, et al. Prevalence of coronary heart disease and major cardiovascular risk factors in Thailand. Int J Epidemiology 1998;27(3):405–409.

    Article  CAS  Google Scholar 

  9. Tokuda Y. Risk factors for acute myocardial infarction among Okinawans. J Nutr Health Aging 2005;9(40):272–276.

    CAS  PubMed  Google Scholar 

  10. Ross MC, Duong D, Wiggins SD, et al. Descriptive study of hypercholesteremia in a Vietnamese population of the Gulf Coast. J Cultural Diversity 2000;7(3):65–71.

    CAS  Google Scholar 

  11. Rissel C, Russel C. Heart disease risk factors in the Vietnamese community of southwest Sydney. Aust J Public Health 1993;17(1):71–73.

    CAS  PubMed  Google Scholar 

  12. Ng TP, Niti M. Trends and ethnic differences in hospital admissions and mortality for congestive heart failure in the elderly in Singapore, 1992–1998. Heart 2003;89(8):865–870

    Article  CAS  PubMed  Google Scholar 

  13. Galasko GI, Senior R, Lahiri A. Ethnic differences in the prevalence and aetiology of left ventricular systolic dysfunction in the community: the Harrow heart failure watch. Heart 2005;91(15):595–600.

    Article  CAS  PubMed  Google Scholar 

  14. Joshi PP, Mohanan CJ, Sengupta SP, et al. Factors precipitating congestive heart failure—role of patient non-compliance. J Assoc Phys India 1999;47(3):294–295.

    CAS  Google Scholar 

  15. Kalim H, Thosin A, Firman D, et al. Clinical profile and management of heart failure in a cardiac centre. Crit Care Shock 2002;5(4):229–234.

    Google Scholar 

  16. Lim MC, Tan TZ, Choo M, et al. Review of patients with infectious endocarditis of native valves over a five year period. Ann Acad Med 1993;22(3):296–299.

    CAS  Google Scholar 

  17. Yandle T, Fisher S, Livesey J, et al. Exponential increase in clinical use of plasma brain batriuretic peptide (BNP) assays. N Z Med J 2004;117(1197):U956.

    PubMed  Google Scholar 

  18. Davis P, Lay-Yee R, Fitzjohn J, et al. Co-morbidity and Health outcomes in three Auckland hospitals. N Z Med J 2002;115(1153):211–125.

    PubMed  Google Scholar 

  19. Carr J, Ronson B, Reid P, et al. Heart failure: ethnic differences in morbidity and mortality in NZ. N Z Med J 2002;115(1146):15–17.

    PubMed  Google Scholar 

  20. Riddell T. Heart failure hospitalisations and deaths in New Zealand: pattern by deprivation and ethnicity. N Z Med J 2005;118(1208):U1254.

    Google Scholar 

  21. Blyth FM, Lazarus R, Ross D, et al. Burden and outcomes of hospitalisation for congestive heart failure. Med J Aust 1997:167(2):61–62.

    Google Scholar 

  22. Campbell DJ. Heart failure: how can we prevent the epidemic? Med J Aust 2003;179(8):422–425.

    PubMed  Google Scholar 

  23. McLean AS, Eslick G, Coats AJ. The epidemiology of heart failure in Australia. Int J Cardiol 2007;118:370–374.

    Article  PubMed  Google Scholar 

  24. Goto T, Takase H, Toriyama T, et al. Circulating concentrations of cardiac proteins indicate the severity of congestive heart failure. Heart 2003;89:1303–1307.

    Article  CAS  PubMed  Google Scholar 

  25. Yasue H, Yoshimura M, Sumida H, et al. Localisation and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994;90:195–203.

    CAS  PubMed  Google Scholar 

  26. McLean AS, Tang B, Nalos M, et al. Increased B-type natriuretic peptide (BNP) level is a strong predictor for cardiac dysfunction in the intensive care unit patients. Anaesth Intensive Care 2003;31:21–27.

    CAS  PubMed  Google Scholar 

  27. Richards AM, Crozier IG, Yandle TG, et al. Brain natriuretic factor: regional plasma concentrations and correlations with hemodynamic state in cardiac disease. Br Heart J 1993;69:414–417.

    Article  CAS  PubMed  Google Scholar 

  28. Mclean AS, Huang SJ. B-Type Natriuretic Peptide to Assess Cardiac Function in the Critically Ill. In: Vincent JL, ed. Yearbook of Intensive Care and Emergency Medicine. Berlin, Germany: Springer-Verlag, 2005:151–160.

    Chapter  Google Scholar 

  29. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantification of the left ventricle by two-dimensional echocardiography. Am Soc Echo 1989;2(5):358–367.

    CAS  Google Scholar 

  30. Nishimura RA, Callahan MJ, Schaff HV, et al. Noninvasive measurement of cardiac output by continuous wave Doppler echocardiography: initial experience and review of the literature. Mayo Clin Proc 1984;59(7):484–489.

    CAS  PubMed  Google Scholar 

  31. Hatle I, Angelsen BA. Doppler Ultrasound in Cardiology, 2nd ed. Philadelphia: Lea & Febiger, 1985.

    Google Scholar 

  32. Izzat MB, Regragui IA, Wilde P, et al. Transoesophageal echocardiography measurements of cardiac output in cardiac surgical patients. Ann Thorac Surg 1994;58:1486–1489.

    CAS  PubMed  Google Scholar 

  33. Varadarajan P, Pai RG. Prognosis of congestive heart failure in patients with normal versus reduced ejection fractions: results from a cohort of 2,258 hospitalized patients. J Cardiac Failure 2003;9:107–112.

    Article  Google Scholar 

  34. Leung JM, Levine EH. Left ventricular endsystolic cavity obliteration as an estimate of intraoperative hypovolaemia. Anesthesiology 1994;81:1102–1109.

    Article  CAS  PubMed  Google Scholar 

  35. Royse CF, Royse AG, Soeding PF, et al. Shape and movement of the interatrial septum predicts change in pulmonary capillary wedge pressure. Ann Thorac Cardiovasc Surg 2001;7:79–83.

    CAS  PubMed  Google Scholar 

  36. Cheung AT, Savino JS, Weiss SJ, et al. Echocardiographic and hemodynamic indexes of left ventricular preload in patients with normal and abnormal ventricular function. Anesthesiology 1994;81:376–387.

    Article  CAS  PubMed  Google Scholar 

  37. Axler O, Tousignant C, Thompson CR, et al. Comparison of transesphageal echocardiographic, fick, and thermodilution cardiac output in critically ill patients. J Crit Care 1996;11:109–116.

    Article  CAS  PubMed  Google Scholar 

  38. Pozzoli M, Traversi E, Roelandt RTC. Noninvasive Estimation of left ventricular filling pressures by Doppler echocardiography. Eur J Echo 2002;3:75–79.

    Article  CAS  Google Scholar 

  39. Giannuzzi P, Imparato A, Temporelli PL, et al. Doppler derived mitral deceleration time of early filling is a strong predictor of pulmonary capillary wedge pressure in postinfarction patients with left ventricular systolic dysfunction. J Am Coll Cardiol 1994;23:1630–1637

    CAS  PubMed  Google Scholar 

  40. Pozzoli M, Capromolla S, Pinna G, et al. Doppler echocardiography reliably predicts pulmonary artery wedge pressure in patients with chronic heart failure with and without mitral regurgitation. J Am Coll Cardiol 1996;27:883–893

    Article  CAS  PubMed  Google Scholar 

  41. Ommen SR, Nishimura RA, Appleton CP, et al. Clinical utility of doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures. Circulation 2000;102:1788–1794

    CAS  PubMed  Google Scholar 

  42. Rossvoll O, Hatle LK. Pulmonary flow velocities recorded by transthoracic Doppler ultrasound: relation to left ventricular diastolic. J Am Coll Cardiol 1993;21:1687–1696

    Article  CAS  PubMed  Google Scholar 

  43. Gonzalez-Vilchez F, Ayuela J, Miguel A, et al. Comparison of Doppler echocardiography, color M-mode Doppler and tissue imaging for the estimation of pulmonary capillary wedge pressure. J Am Soc Echo 2002;15:1245–1250.

    Article  Google Scholar 

  44. Gorscan J, Snow FR, Paulson W, et al. Noninvasive estimation of left atrial pressure in patients with congestive heart failure and mitral regurgitation by Doppler echocardiography. Am Heart J 1991;121:858–863.

    Article  Google Scholar 

  45. Kircher BJ, Himelman RB, Schiller NB. Non-invasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cava. Am J Cardiol 1990;66:493.

    Article  CAS  PubMed  Google Scholar 

  46. Vieillard-Baron A, Chergui K, Rabilks A, et al. Superior venacava collapsibility as a gauge of volume status in ventilated septic patients. Intensive Care Med 2004;30:1734–1739.

    PubMed  Google Scholar 

  47. Wittstein IS, Thiemann DR, Lima JA, et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 2005;352:539–548.

    Article  CAS  PubMed  Google Scholar 

  48. Akashi YJ, Nakazawa K, Sakakibara M, et al. The Clinical features of Takotsubo cardiomyopathy. OJM 2003;96(8):563–573.

    CAS  Google Scholar 

  49. Watanabe H, Kodama M, Okura Y, et al. Impact of earthquake on Takotsuba cardiomyopathy. JAMA 2005;294(3):305–307.

    Article  CAS  PubMed  Google Scholar 

  50. Cotter G, Metzkor E, Kaluski E, et al. Randomised trial of high-dose isosorbide dinitrate plus lowdose furosemide versus high-dose furosemide plus low-dose isosorbide in severe pulmonary oedema. Lancet 1998;351:389–393.

    Article  CAS  PubMed  Google Scholar 

  51. Nieminen MS, Bohm M, Lowie MR, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Taskforce on Acute Heart Failure of the ESC. Eur Heart J 2005;26:384–416.

    Article  PubMed  Google Scholar 

  52. Bertini G, Gilioli C, Biggeri A, et al. Intravenous nitrates in the prehospital management of acute pulmonary oedema. Ann Emerg Med 1998;31:493–499.

    Google Scholar 

  53. Panacek EA, Kirk JD. Role of non-invasive ventilation in the management of acutely decompensated heart failure. Rev Cardiovasc Med 2002;3(4):S35–S40.

    PubMed  Google Scholar 

  54. Kaye DM, Mansfield D, Naughton MT. Continuous Positive airway pressure decreases myocardial oxygen consumption in heart failure. Clin Sci 2004;106(6):599–603.

    Article  PubMed  Google Scholar 

  55. Kaye DM, Mansfield D, Aggawal A, et al. Acute effects of continuous airway pressure on cardiac sympathetic tone in congestive heart failure. Circulation 2001;103(19):2336–2338.

    CAS  PubMed  Google Scholar 

  56. Felker GM, O’Conner CM. Inotropic therapy for heart failure: an evidence-based approach. Am Heart J 2001;142:393–401.

    Article  CAS  PubMed  Google Scholar 

  57. Thackray S, Easthaugh J, Freemantle N, et al. The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure—a meta-regression analysis. Eur J Heart Fail 2002;4:515–529.

    Article  CAS  PubMed  Google Scholar 

  58. Cuffe MS, Califf RM, Adams KF, et al. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomised controlled trial (OPTIME). JAMA 2002;287:1541–1547.

    Article  CAS  PubMed  Google Scholar 

  59. Ukkonen H, Saraste M, Akkila J, et al. Myocardial efficiency during calcium sensitisation with levosimendan; a non-invasive study with positron emission tomography and echocardiography in healthy volunteers. Clin Pharmacol Ther 1997;61:596–607.

    Article  CAS  PubMed  Google Scholar 

  60. Follath F, Cleland JGF, Just JGY, et al. Efficacy and safety of intravenous levosimendan compared to dobutamine in severe low-output heart failure: a randomised double-blind trial. Lancet 2002;360:196–202.

    Article  CAS  PubMed  Google Scholar 

  61. Moiseyev VS, Poder P, Andrejevs N, et al. Safety and efficacy of a novel calcium sensitiser, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. Eur Heart J 2002;23:1422–1432.

    Article  CAS  PubMed  Google Scholar 

  62. McLean AS, Huang SJ, Nalos M, et al. Duration of the beneficial effects of levosimendan in decompensated heart failure as measured by echocardiographic and B-type natriuretic peptide. J Cardiovasc Pharmacol 2005;46:830–835

    Article  CAS  PubMed  Google Scholar 

  63. Cleland JGF, Freemantle N, Coletta AP, et al. Clinical trials update from the American Heart Association. Eur J Heart Failure 2006;8:105–110.

    Article  CAS  Google Scholar 

  64. Topol E. Nesiritide—not verified. N Engl J Med 2005;353:113–116.

    Article  PubMed  Google Scholar 

  65. Cleland JGF, Coletta AP, Lammiman M, et al. Clinical trials update from the European Society of Cardiology Meeting 2005. Eur J Heart Failure 2005;7:1070–1075.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Intensive Care Medicine, Nepean Hospital, Penrith, Sydney, Australia

    Anthony S. McLean MB, ChB, BSc (Hons), FRACP

Authors
  1. Anthony S. McLean MB, ChB, BSc (Hons), FRACP
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Anesthesiology and Critical Care Medicine, Lariboisière University Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris Diderot, Paris, France

    Alexandre Mebazaa MD, PhD (Professor of Medicine) (Professor of Medicine)

  2. Feinberg School of Medicine, Northwestern University, Chicago, IL, USA

    Mihai Gheorghiade MD, FACC (Professor of Medicine and Surgery, Associate Chief, Division of Cardiology and Chief, Cardiology Clinical Service) (Professor of Medicine and Surgery, Associate Chief, Division of Cardiology and Chief, Cardiology Clinical Service)

  3. Department of Cardiology Centre d’Investigation Clinique (CIC), INSERM U-684, Centre Hospitalier Universitaire, University Henri Poincaré, Nancy, France

    Faiez M. Zannad MD, PhD, FESC (Professor of Medicine) (Professor of Medicine)

  4. Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, Camden, NJ, USA

    Joseph E. Parrillo MD (Professor of Medicine, Chief, Department of Medicine Edward D. Viner MD Chair, Department of Medicine and Director) (Professor of Medicine, Chief, Department of Medicine Edward D. Viner MD Chair, Department of Medicine and Director)

  5. Cooper Heart Institute, Cooper University Hospital, Camden, NJ, USA

    Joseph E. Parrillo MD (Professor of Medicine, Chief, Department of Medicine Edward D. Viner MD Chair, Department of Medicine and Director) (Professor of Medicine, Chief, Department of Medicine Edward D. Viner MD Chair, Department of Medicine and Director)

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag London Limited

About this chapter

Cite this chapter

McLean, A.S. (2008). Epidemiology and Management of Acute Decompensating Heart Failure in the Asia-Pacific Region. In: Mebazaa, A., Gheorghiade, M., Zannad, F.M., Parrillo, J.E. (eds) Acute Heart Failure. Springer, London. https://doi.org/10.1007/978-1-84628-782-4_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-84628-782-4_4

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84628-781-7

  • Online ISBN: 978-1-84628-782-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation